FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027931726> ?p ?o ?g. }

• W2027931726 endingPage "646" @default.
• W2027931726 startingPage "637" @default.
• W2027931726 abstract "To study human teratogenic potential of two trimethoprim-sulfonamide combinations: trimethoprim-sulfamethoxazole (cotrimoxazole) and trimethoprim-sulfamethazine during pregnancy. These agents have antifolate effects and other antifolate agents can induce multiple congenital abnormalities, neural-tube defects, cardiovascular, and other malformations in animal experiments and in humans.Pair analysis of cases with congenital abnormalities and matched healthy controls in the large population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996.38,151 pregnant women who had newborn infants without any congenital abnormalities (control group) and 22,865 case pregnant women who had newborns or fetuses with congenital abnormalities.Prevalence of drug use in matched case-control pairs to study the possible association with congenital abnormalities.In the case group 351 (1.5%) and in the control group 443 (1.2%) pregnant women were treated with cotrimoxazole (crude OR 1.3 with 95% CI 1.1-1.5). In addition 45 (0.2%) case and 39 (0.1%) control pregnant women had trimethoprim-sulfamethazine treatment (crude OR 1.9 with 95% CI 1.3-3.0). A higher rate of multiple congenital abnormalities (including mainly urinary tract and cardiovascular abnormalities) was found in case infants born to mothers with cotrimoxazole treatment during the second-third months of pregnancy. In addition, a higher rate of cardiovascular malformations occurred in cases born to mothers with cotrimoxazole treatment and trimethoprim-sulfamethazine treatment during the second-third months of pregnancy, respectively.Treatment with cotrimoxazole during pregnancy may increase the risk of cardiovascular malformations, and particularly multiple congenital abnormalities including defects of the urinary tract and cardiovascular system. A higher rate of cardiovascular malformations was also found after treatment with trimethoprim-sulfamethazine in the second-third months of pregnancy." @default.
• W2027931726 created "2016-06-24" @default.
• W2027931726 creator A5020981760 @default.
• W2027931726 creator A5031904164 @default.
• W2027931726 creator A5033040903 @default.
• W2027931726 creator A5082531754 @default.
• W2027931726 date "2001-11-01" @default.
• W2027931726 modified "2023-10-05" @default.
• W2027931726 title "The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study" @default.
• W2027931726 cites W1481448793 @default.
• W2027931726 cites W1974475255 @default.
• W2027931726 cites W1975546469 @default.
• W2027931726 cites W1980775375 @default.
• W2027931726 cites W1981841305 @default.
• W2027931726 cites W1990578835 @default.
• W2027931726 cites W1990642671 @default.
• W2027931726 cites W1993444518 @default.
• W2027931726 cites W1999968416 @default.
• W2027931726 cites W2006511369 @default.
• W2027931726 cites W2026224538 @default.
• W2027931726 cites W2027804269 @default.
• W2027931726 cites W2030771384 @default.
• W2027931726 cites W2041585513 @default.
• W2027931726 cites W2042502773 @default.
• W2027931726 cites W2048960853 @default.
• W2027931726 cites W2050651040 @default.
• W2027931726 cites W2053219426 @default.
• W2027931726 cites W2063326422 @default.
• W2027931726 cites W2072585564 @default.
• W2027931726 cites W2084124152 @default.
• W2027931726 cites W2084879395 @default.
• W2027931726 cites W2105405212 @default.
• W2027931726 cites W2116527490 @default.
• W2027931726 cites W2120418560 @default.
• W2027931726 cites W2133607391 @default.
• W2027931726 cites W2156555817 @default.
• W2027931726 cites W2159328632 @default.
• W2027931726 cites W2167358139 @default.
• W2027931726 cites W2167415087 @default.
• W2027931726 cites W2175980302 @default.
• W2027931726 cites W2191243435 @default.
• W2027931726 cites W2321860569 @default.
• W2027931726 cites W2325417132 @default.
• W2027931726 cites W2325954328 @default.
• W2027931726 cites W2412763215 @default.
• W2027931726 cites W4206832593 @default.
• W2027931726 cites W4237533794 @default.
• W2027931726 doi "https://doi.org/10.1016/s0890-6238(01)00178-2" @default.
• W2027931726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11738517" @default.
• W2027931726 hasPublicationYear "2001" @default.
• W2027931726 type Work @default.
• W2027931726 sameAs 2027931726 @default.
• W2027931726 citedByCount "114" @default.
• W2027931726 countsByYear W20279317262012 @default.
• W2027931726 countsByYear W20279317262013 @default.
• W2027931726 countsByYear W20279317262014 @default.
• W2027931726 countsByYear W20279317262015 @default.
• W2027931726 countsByYear W20279317262016 @default.
• W2027931726 countsByYear W20279317262017 @default.
• W2027931726 countsByYear W20279317262018 @default.
• W2027931726 countsByYear W20279317262019 @default.
• W2027931726 countsByYear W20279317262020 @default.
• W2027931726 countsByYear W20279317262021 @default.
• W2027931726 countsByYear W20279317262022 @default.
• W2027931726 countsByYear W20279317262023 @default.
• W2027931726 crossrefType "journal-article" @default.
• W2027931726 hasAuthorship W2027931726A5020981760 @default.
• W2027931726 hasAuthorship W2027931726A5031904164 @default.
• W2027931726 hasAuthorship W2027931726A5033040903 @default.
• W2027931726 hasAuthorship W2027931726A5082531754 @default.
• W2027931726 hasConcept C126322002 @default.
• W2027931726 hasConcept C131872663 @default.
• W2027931726 hasConcept C141071460 @default.
• W2027931726 hasConcept C146304588 @default.
• W2027931726 hasConcept C187212893 @default.
• W2027931726 hasConcept C2776694085 @default.
• W2027931726 hasConcept C2778397455 @default.
• W2027931726 hasConcept C2779234561 @default.
• W2027931726 hasConcept C2779425571 @default.
• W2027931726 hasConcept C2780728791 @default.
• W2027931726 hasConcept C2781382166 @default.
• W2027931726 hasConcept C2908647359 @default.
• W2027931726 hasConcept C46973012 @default.
• W2027931726 hasConcept C501593827 @default.
• W2027931726 hasConcept C54355233 @default.
• W2027931726 hasConcept C65290608 @default.
• W2027931726 hasConcept C71924100 @default.
• W2027931726 hasConcept C77411442 @default.
• W2027931726 hasConcept C86803240 @default.
• W2027931726 hasConcept C89423630 @default.
• W2027931726 hasConcept C99454951 @default.
• W2027931726 hasConceptScore W2027931726C126322002 @default.
• W2027931726 hasConceptScore W2027931726C131872663 @default.
• W2027931726 hasConceptScore W2027931726C141071460 @default.
• W2027931726 hasConceptScore W2027931726C146304588 @default.
• W2027931726 hasConceptScore W2027931726C187212893 @default.
• W2027931726 hasConceptScore W2027931726C2776694085 @default.
• W2027931726 hasConceptScore W2027931726C2778397455 @default.

• next